In Other News

• Gene Expression Test Supports Metastatic Risk Assessment in Melanoma

• Framework Outlines Genomic Testing Strategy for Safer Drug Dosing in Africa

• AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers

• AI Lab Analytics Platform Proactively Optimizes Clinical Laboratory Operations

• CSF Sequencing Test Aligns with Updated Brain Tumor Guidelines

• Point-of-Care PCR Panel Delivers Vaginitis Results in 20 Minutes

• Partnership Integrates Automated DNA Extraction with Single-Molecule Digital PCR

• Blood Test Reveals Hidden Pancreatic Cancer After Treatment

• Bringing laboratory diagnostics to space

• Measuring what matters: advancing diversity, equity, and inclusion in lab medicine

• Academy guidance on data analytics: Preparing clinical labs for a data-driven future

• H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention

• Model Predicts Increased ALS Clinic Visits with Expanded Genetic Testing

• Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV

• Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission

• Genomic Assays Predict Anthracycline Benefit in Early-Stage Breast Cancer

• Gene Expression Test Refines Melanoma Biopsy Decision-Making

• Gene Variants Linked to Pollution-Exacerbated Asthma

• Gene Expression Test Refines Melanoma Biopsy Decision-Making

• Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

• Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

• Gene Variants Linked to Pollution-Exacerbated Asthma

• Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer